End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
62.8 BDT | -2.94% | -4.41% | -21.11% |
Sales 2022 | 9.66B 87.85M 7.32B | Sales 2023 | 13.93B 127M 10.56B | Capitalization | 18.63B 169M 14.12B |
---|---|---|---|---|---|
Net income 2022 | 846M 7.69M 641M | Net income 2023 | 641M 5.83M 486M | EV / Sales 2022 | 4.04 x |
Net Debt 2022 | 18.45B 168M 13.98B | Net Debt 2023 | 21.7B 197M 16.45B | EV / Sales 2023 | 2.9 x |
P/E ratio 2022 |
24.3
x | P/E ratio 2023 |
29.1
x | Employees | 2,716 |
Yield 2022 |
1.14% | Yield 2023 |
1.26% | Free-Float | 68.02% |
1 day | -2.94% | ||
1 week | -4.41% | ||
Current month | -11.92% | ||
1 month | -6.13% | ||
3 months | -21.11% | ||
6 months | -21.11% | ||
Current year | -21.11% |
Managers | Title | Age | Since |
---|---|---|---|
Zareen Karim
CEO | Chief Executive Officer | 46 | 01/10/01 |
Monowara Khatoon
DFI | Director of Finance/CFO | - | - |
Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mohammad Karim
CHM | Chairman | 69 | - |
Arzuda Karim
BRD | Director/Board Member | 68 | 01/85/01 |
Director/Board Member | 42 | 01/10/01 |
Date | Price | Change | Volume |
---|---|---|---|
25/24/25 | 62.8 | -2.94% | 687,611 |
24/24/24 | 64.7 | 0.00% | 857,342 |
23/24/23 | 64.7 | -1.37% | 735,632 |
22/24/22 | 65.6 | +1.86% | 500,973 |
21/24/21 | 64.4 | -1.98% | 749,534 |
End-of-day quote Dhaka S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-21.11% | 134M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ORIONPHARM Stock